Therapeutic effects of ivabradine on hemodynamic parameters and cardiotoxicity induced by doxorubicin treatment in rat

Dose-Dependent Protective Effect of Ivabradine against Ischemia-Reperfusion-Induced Renal Injury in Rats

(2011) Ali Beytur et al.   KIDNEY & BLOOD PRESSURE RESEARCH

Ivabradine: from molecular basis to clinical effectiveness

(2010) Graziano Riccioni   ADVANCES IN THERAPY

Chronic Heart Rate Reduction Facilitates Cardiomyocyte Survival After Myocardial Infarction

(2010) Rong-Lin Zhang et al.   Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology

Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice

(2010) Magnus Baumhäkel et al.   ATHEROSCLEROSIS

Effect of methimazole treatment on doxorubicin-induced cardiotoxicity in mice

(2009) Abdel-Moneim M. Osman et al.   FOOD AND CHEMICAL TOXICOLOGY

Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidaemic mice

(2008) A Drouin et al.   BRITISH JOURNAL OF PHARMACOLOGY

Pleiotropic action(s) of the bradycardic agent ivabradine: cardiovascular protection beyond heart rate reduction

(2008) G Heusch   BRITISH JOURNAL OF PHARMACOLOGY

Central endothelin: effects on vasopressin and the arterial baroreflex in doxorubicin heart failure ratsThis article is one of a selection of papers published in the special issue (part 1 of 2) on Forefronts in Endothelin.

(2008) Noreen F. Rossi et al.   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Heart Rate Reduction by Ivabradine Reduces Oxidative Stress, Improves Endothelial Function, and Prevents Atherosclerosis in Apolipoprotein E–Deficient Mice

(2008) Florian Custodis et al.   CIRCULATION

Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction

(2008) G. Heusch et al.   EUROPEAN HEART JOURNAL